Table 2.
Immunohistochemistry results of four targets in non-dysplastic Barrett’s esophagus.
| Targets | H-Score NDBE | High (201–300) | Intermediate (101–200) | Negative–Low (0–100) | |||||
|---|---|---|---|---|---|---|---|---|---|
| n | Mean (SD) | Mean Value | n | % | n | % | n | % | |
| SULF1 | 59 | 55 (33) | Negative–low | 0 | 0 | 4 | 6.78 | 55 | 93.22 |
| PKCι | 56 | 67 (31) | Negative–low | 0 | 0 | 8 | 14.29 | 48 | 85.71 |
| DDR1 | 59 | 137 (50) | Intermediate | 5 | 8.47 | 46 | 77.97 | 8 | 13.56 |
| SPARC | 58 | 120 (59) | Intermediate | 4 | 6.90 | 29 | 50 | 25 | 43.10 |
H-score of 0–100 is classified as negative–low; H-score of 101–200 is classified as intermediate; H-score of 201–300 is classified as high. Mean intensities and standard deviation are shown using the H-score. NDBE: non-dysplastic Barrett’s esophagus; SD: standard deviation.